Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1986 May;64(2):249–254.

Thyrotrophin (TSH) binding sites on Yersinia enterocolitica recognized by immunoglobulins from humans with Graves' disease.

P Heyma, L C Harrison, R Robins-Browne
PMCID: PMC1542330  PMID: 3017619

Abstract

Antibodies against the gram negative enteric bacterium Yersinia enterocolitica have been found in a high proportion of persons with autoimmune thyroid disorders, especially in those with Graves' disease or hyperthyroidism (Shenkman & Bottone, 1981). There is strong evidence that Graves' disease is caused by receptor autoantibodies which mimic the bioeffects of thyroid stimulating hormone (TSH) on the thyroid (Manley, Knight & Adams, 1982). Recently, saturable binding sites for TSH were demonstrated in Y. enterocolitica under non-physiological conditions (Weiss et al., 1983). We have characterized TSH binding sites on Y. enterocolitica under physiological conditions and studied their interaction with Graves' immunoglobulins (Ig's). Saturable and specific binding of receptor-purified 125I-TSH to lysozyme/EDTA-treated Y. enterocolitica (serotype 03) was demonstrated under both non-physiological and physiological conditions. Scatchard binding plots were linear indicating a single class of binding site (Kd 1 X 10(-7) M, maximum of 30,000 binding sites per cell). In the presence of Graves' Ig's the binding of 125I-TSH to Y. enterocolitica was significantly inhibited. Graves' Ig's also precipitated a protein of relative molecular mass (Mr) 64,000 from Triton-solubilized, 125I-labelled Y. enterocolitica, similar in size to one of the proteins precipitated by Graves' Ig's from human thyroid membranes. These findings are consistent with the hypothesis that thyroid autoimmunity may be triggered by bacterial infection via a mechanism involving crossreactivity at the level of the TSH receptor. They also suggest that elements of mammalian endocrine systems are highly conserved and have a function in prokaryotes.

Full text

PDF
249

Images in this article

252Fig. 3
on p.252

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown R. S., Kertiles L. P., Reichlin S. Partial purification and characterization of thyrotropin binding inhibitory immunoglobulins from normal human plasma. J Clin Endocrinol Metab. 1983 Jan;56(1):156–163. doi: 10.1210/jcem-56-1-156. [DOI] [PubMed] [Google Scholar]
  2. Edmonds J., Macauley D., Tyndall A., Liew M., Alexander K., Geczy A., Bashir H. Lymphocytotoxicity of anti-Klebsiella antisera in ankylosing spondylitis and related arthropathies: patient and family studies. Arthritis Rheum. 1981 Jan;24(1):1–7. doi: 10.1002/art.1780240101. [DOI] [PubMed] [Google Scholar]
  3. Edmonds J. Reactive arthritis. Aust N Z J Med. 1984 Feb;14(1):81–88. doi: 10.1111/j.1445-5994.1984.tb03597.x. [DOI] [PubMed] [Google Scholar]
  4. Heyma P., Harrison L. C. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins. J Clin Invest. 1984 Sep;74(3):1090–1097. doi: 10.1172/JCI111476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hinds W. E., Takai N., Rapoport B., Filetti S., Clark O. H. Thyroid-stimulating immunoglobulin bioassay using cultured human thyroid cells. J Clin Endocrinol Metab. 1981 Jun;52(6):1204–1210. doi: 10.1210/jcem-52-6-1204. [DOI] [PubMed] [Google Scholar]
  6. KAPLAN M. H., MEYESERIAN M. An immunological cross-reaction between group-A streptococcal cells and human heart tissue. Lancet. 1962 Apr 7;1(7232):706–710. doi: 10.1016/s0140-6736(62)91653-7. [DOI] [PubMed] [Google Scholar]
  7. Kleinmann R. E., Braverman L. E., Vagenakis A. G., Butcher R. W., Clark R. B. A new method for measurement of human thyroid-stimulating immunoglobulins. J Lab Clin Med. 1980 Apr;95(4):581–589. [PubMed] [Google Scholar]
  8. Lidman K., Eriksson U., Norberg R., Fagraeus A. Indirect immunofluorescence staining of human thyroid by antibodies occurring in Yersinia enterocolitica infections. Clin Exp Immunol. 1976 Mar;23(3):429–435. [PMC free article] [PubMed] [Google Scholar]
  9. Manley S. W., Knight A., Adams D. D. The thyrotrophin receptor. Springer Semin Immunopathol. 1982;5(4):413–431. doi: 10.1007/BF01857428. [DOI] [PubMed] [Google Scholar]
  10. McKenzie J. M., Zakarija M., Sato A. Humoral immunity in Graves' disease. Clin Endocrinol Metab. 1978 Mar;7(1):31–45. doi: 10.1016/s0300-595x(78)80034-6. [DOI] [PubMed] [Google Scholar]
  11. Pekonen F., Weintraub B. D. Thyrotropin receptors on bovine thyroid membranes: two types with different affinities and specificities. Endocrinology. 1979 Aug;105(2):352–359. doi: 10.1210/endo-105-2-352. [DOI] [PubMed] [Google Scholar]
  12. REPASKE R. Lysis of gram-negative bacteria by lysozyme. Biochim Biophys Acta. 1956 Oct;22(1):189–191. doi: 10.1016/0006-3002(56)90240-2. [DOI] [PubMed] [Google Scholar]
  13. Smith B. R., Hall R. Thyroid-stimulating immunoglobulins in Graves' disease. Lancet. 1974 Aug 24;2(7878):427–431. doi: 10.1016/s0140-6736(74)91815-7. [DOI] [PubMed] [Google Scholar]
  14. Stefansson K., Dieperink M. E., Richman D. P., Gomez C. M., Marton L. S. Sharing of antigenic determinants between the nicotinic acetylcholine receptor and proteins in Escherichia coli, Proteus vulgaris, and Klebsiella pneumoniae. Possible role in the pathogenesis of myasthenia gravis. N Engl J Med. 1985 Jan 24;312(4):221–225. doi: 10.1056/NEJM198501243120407. [DOI] [PubMed] [Google Scholar]
  15. Weiss M., Ingbar S. H., Winblad S., Kasper D. L. Demonstration of a saturable binding site for thyrotropin in Yersinia enterocolitica. Science. 1983 Mar 18;219(4590):1331–1333. doi: 10.1126/science.6298936. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES